{
  "docId": "019f6b8f-155a-7627-ae9c-99e7272d705f",
  "docSlug": "jarvis-engine-capital-houghton-mifflin-harcourt-presentation-march-2022",
  "documentTitle": "Engine Capital Houghton Mifflin Harcourt Presentation March 2022",
  "authorId": "engine-capital-houghton-mifflin-harcourt-presentation-march-2022",
  "authorName": null,
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 9,
  "pageCount": 21,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The chart uses a projection line to illustrate the gap between the offer price and the implied fair value.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8f-155a-7627-ae9c-99e7272d705f/9",
  "deckHref": "/decks/019f6b8f-155a-7627-ae9c-99e7272d705f",
  "deckJsonHref": "/decks/019f6b8f-155a-7627-ae9c-99e7272d705f.json",
  "deckAnchorHref": "/decks/019f6b8f-155a-7627-ae9c-99e7272d705f#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.92,
        "x": 0.04,
        "y": 0.52
      },
      "kind": "chart",
      "text": "HMHC Stock Chart (11/4/2021 – 1/13/2022)",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28130161-f603-4290-8573-f8c1fdb3921e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "list",
      "text": "From Q3 2021 earnings until the media leak, HMHC traded at a VWAP of $16.01, implying HMHC was trading at a multiple of 10.25x the midpoint of the 2021 UFCF guidance of $195 million\nOn February 24, 2022, HMHC delivered strong Q4 results with 2021 billings and UFCF ($1,110 billion and $203 million) well above the midpoint of its 2021 guidance ($1,085 million and $195 million). HMHC would also have provided strong guidance for 2022 given management's forecast per the Schedule 14D-9 and announced a refinancing. We expect the stock would have reacted very positively\nIf we apply that 10.25x multiple on 2022 UFCF of $220 million and use the Q4 balance sheet information, HMHC would be at $18.25 implying a premium of 15%. Since HMHC would have refinanced its debt and probably would have initiated a share buyback, we believe the multiple would have expanded. At 11x 2022 UFCF, the stock would be at $19.50 per share. At 12x 2022 UFCF, the stock would be at $21.2 per share.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f80b9ae-0b5c-40c9-a1fe-baa34b73a3a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.19,
        "y": 0.92
      },
      "kind": "other",
      "text": "Notes: (1) $16.01 VWAP calculated from 11/4/2021 to 1/13/2022",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46df9391-bce4-4a54-9054-c454a6a0872c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.92,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Engine believes that following strong Q4 results, HMHC stock would have traded at or above $19.50 per share, implying the Veritas offer represents an insufficient premium of 7.7% instead of the 36% premium the Company is advertising based on an artificial low point tied to a media leak. Applying a 30% change of control premium to that $19.50 number points to a fair transaction value of $25.35 per share",
      "attrs": null,
      "subkind": "description",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d81bff9c-cbfb-4665-a862-0021ff3d8afe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "The $21 per share doesn't provide a sufficient premium when compared to where the stock would be following strong Q4 results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d7bc26d-b66e-4bce-8a80-37de265bd798",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "valuation-bridge",
      "slug": null,
      "matchId": "4b256e96-0b0a-46ba-8a03-bbb8051d1d18",
      "evidence": "The chart shows a bridge from current trading price to projected fair value based on Q4 results.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 6,
      "beatId": "c6917caa-12c6-425e-8da7-fcc510eea151",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document highlights the flaws in the sales process and the undervaluation of the company",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}